Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alaunos Therapeutics Inc (TCRT)

Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alaunos Therapeutics Inc 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005 USA

www.alaunos.com P: 346-355-4099

Description:

Alaunos Therapeutics Inc. is a clinical-stage oncology-focused cell therapy company. It focused on developing T-cell receptor therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform. Alaunos Therapeutics Inc., formerly known as Ziopharm Oncology Inc., is based in HOUSTON.

Key Statistics

Overview:

Market Capitalization, $K 19,855
Enterprise Value, $K 13,795
Shares Outstanding, K 16,012
Annual Sales, $ 10 K
Annual Net Income, $ -35,140 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,840 K
EBIT, $ -34,260 K
EBITDA, $ -30,610 K
60-Month Beta -0.33
% of Insider Shareholders 6.18%
% of Institutional Shareholders 27.72%
Float, K 15,022
% Float 93.82%
Short Volume Ratio 0.13

Growth:

1-Year Return -84.53%
3-Year Return -97.52%
5-Year Return -98.19%
5-Year Revenue Growth -93.33%
5-Year Earnings Growth 73.61%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.60 on 11/14/23
Latest Earnings Date 05/08/24
Earnings Per Share ttm -1.80
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 02/01/24

TCRT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -196.96%
Return-on-Assets % -134.81%
Profit Margin % -351,400.00%
Debt/Equity 0.00
Price/Sales 4,131.10
Price/Cash Flow N/A
Price/Book 3.56
Book Value/Share 0.39
Interest Coverage -17.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar